{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:42:25Z","timestamp":1789562545680,"version":"build-2803163510"},"reference-count":21,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["30971283"],"award-info":[{"award-number":["30971283"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["31100638"],"award-info":[{"award-number":["31100638"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81170502"],"award-info":[{"award-number":["81170502"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Zhejiang Provincial Natural Science Foundation of China","award":["Y2110020"],"award-info":[{"award-number":["Y2110020"]}]},{"name":"Zhejiang Provincial Natural Science Foundation of China","award":["Z205166"],"award-info":[{"award-number":["Z205166"]}]},{"name":"Zhejiang Provincial Fund of Science and Technology Bureau","award":["2007C23007"],"award-info":[{"award-number":["2007C23007"]}]},{"name":"the Fundamental Research Funds for the Central Universities"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.leukres.2012.03.014","type":"journal-article","created":{"date-parts":[[2012,4,5]],"date-time":"2012-04-05T13:01:09Z","timestamp":1333630869000},"page":"1022-1027","source":"Crossref","is-referenced-by-count":17,"title":["Day 22 of induction therapy is important for minimal residual disease assessment by flow cytometry in childhood acute lymphoblastic leukemia"],"prefix":"10.1016","volume":"36","author":[{"given":"Xiao-Jun","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Min","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Qiang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Long","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Wen","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Qun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2012.03.014_bib0005","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1182\/blood-2009-10-248146","article-title":"Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study","volume":"115","author":"Conter","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2012.03.014_bib0010","doi-asserted-by":"crossref","first-page":"5477","DOI":"10.1182\/blood-2008-01-132837","article-title":"Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study","volume":"111","author":"Borowitz","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2012.03.014_bib0015","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1365-2141.2009.07744.x","article-title":"Clinical significance of minimal residual disease at day 15 and at the end of therapy in childhood acute lymphoblastic leukaemia","volume":"146","author":"Sutton","year":"2009","journal-title":"Brit J Haematol"},{"key":"10.1016\/j.leukres.2012.03.014_bib0020","doi-asserted-by":"crossref","first-page":"5168","DOI":"10.1200\/JCO.2008.20.8934","article-title":"Risk of relapse of childhood acute lymphoblastic leukemia is predicted by flow cytometric measurement of residual disease on day 15 bone marrow","volume":"27","author":"Basso","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2012.03.014_bib0025","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.leukres.2009.11.031","article-title":"Combined analysis of minimal residual disease at two time points and its value for risk stratification in childhood B-lineage acute lymphoblastic leukemia","volume":"34","author":"Cui","year":"2010","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2012.03.014_bib0030","first-page":"290","article-title":"Detection of minimal residual disease in pediatric patients with acute lymphoblastic leukemia and its prognostic significance","volume":"3","author":"Bai","year":"2007","journal-title":"World J Pediatr"},{"key":"10.1016\/j.leukres.2012.03.014_bib0035","first-page":"400","article-title":"Clinical significance of sequential monitoring minimal residual disease in childhood B-cell acute lymphoblastic leukemia","volume":"32","author":"Wang","year":"2011","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"10.1016\/j.leukres.2012.03.014_bib0040","first-page":"5","article-title":"Prognostic value of early treatment response in children with acute lymphoblastic leukemia: a single institution experience in Shanghai, China","volume":"11","author":"Tie","year":"2009","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"10.1016\/j.leukres.2012.03.014_bib0045","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.hoc.2009.07.010","article-title":"Role of minimal residual disease monitoring in adult and pediatric acute lymphoblastic leukemia","volume":"23","author":"Campana","year":"2009","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.leukres.2012.03.014_bib0050","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/leu.2009.268","article-title":"Standardized MRD quantification in European ALL trials: proceedings of the second international symposium on MRD assessment in Kiel, Germany, 18\u201320 September 2008","volume":"24","author":"Bruggemann","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2012.03.014_bib0055","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/sj.leu.2404603","article-title":"Why and how to quantify minimal residual disease in acute lymphoblastic leukemia?","volume":"21","author":"Szczepanski","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2012.03.014_bib0060","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1080\/10428190600886164","article-title":"Use of five-color staining improves the sensitivity of multiparameter flow cytomeric assessment of minimal residual disease in patients with acute myeloid leukemia","volume":"48","author":"Kern","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.leukres.2012.03.014_bib0065","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/pbc.21629","article-title":"Long-term outcome of childhood acute lymphoblastic leukemia treated in China","volume":"51","author":"Tang","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.leukres.2012.03.014_bib0070","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1182\/blood.V99.6.1952","article-title":"Prognostic significance and modalities of flow cytometric minimal residual disease detection in childhood acute lymphoblastic leukemia","volume":"99","author":"Dworzak","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2012.03.014_bib0075","doi-asserted-by":"crossref","first-page":"521a","DOI":"10.1182\/blood.V108.11.1842.1842","article-title":"Standardized 4 color flow cytometric minimal residual disease detection failed to overcome regeneration problems but identifies early blast clearence predictive of molecular remission after induction in childhood B lineage leukemia","volume":"108","author":"Mejstrikova","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2012.03.014_bib0080","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1182\/blood.V98.8.2498","article-title":"Immunophenotypic analysis of hematogones (B-lymphocyte precursors) in 662 consecutive bone marrow specimens by 4-color flow cytometry","volume":"98","author":"McKenna","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2012.03.014_bib0085","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.leukres.2011.07.004","article-title":"A report about treatment refusal and abandonment in children with acute lymphoblastic leukemia in China, 1997\u20132007","volume":"35","author":"Wang","year":"2011","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2012.03.014_bib0090","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJM199806043382304","article-title":"Augmented post-induction therapy for children with high-risk acute lymphoblastic leukemia and a slow response to initial therapy","volume":"338","author":"Nachman","year":"1998","journal-title":"New Engl J Med"},{"key":"10.1016\/j.leukres.2012.03.014_bib0095","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/leu.2008.324","article-title":"Monitoring treatment response of childhood precursor B-cell acute lymphoblastic leukemia in the AIEOP-BFM-ALL 2000 protocol with multiparameter flow cytometry: predictive impact of early blast reduction on the remission status after induction","volume":"23","author":"Ratei","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2012.03.014_bib0100","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.3324\/haematol.2011.042937","article-title":"Minimal residual disease in peripheral blood at day 15 identifies a subgroup of childhood B-cell precursor acute lymphoblastic leukemia with superior prognosis","volume":"96","author":"Volejnikova","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2012.03.014_bib0105","first-page":"1453","article-title":"Prognostic value of persistent peripheral blood and bone marrow lymphoblasts on day 15 of therapy in childhood acute lymphoblastic leukemia as detected by flow cytometry","volume":"31","author":"Jaworska-Posadzy","year":"2011","journal-title":"Anticancer Res"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212612001361?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212612001361?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,5]],"date-time":"2020-07-05T13:06:37Z","timestamp":1593954397000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212612001361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":21,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0145212612001361"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2012.03.014","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}